Fred Billingsley
About Fred Billingsley
Fred Billingsley is an Associate Director at Sonoma Biotherapeutics, with a background in quality assurance and manufacturing spanning over two decades. He has held various positions at notable companies including Hospira, Lonza, and Baxter BioScience.
Current Role at Sonoma BioTherapeutics
Fred Billingsley serves as the Associate Director at Sonoma Biotherapeutics, a position he has held since 2022. He is based in Seattle, Washington, where he contributes to the company's initiatives in biotherapeutics. His role involves overseeing various quality assurance processes and ensuring compliance with industry standards.
Previous Experience at Hospira
Fred Billingsley worked at Hospira in two significant roles. He served as the Senior Manufacturing Quality Supervisor for one year from 2012 to 2013. Following this, he held the position of Manager, Quality Assurance from 2013 to 2020, where he was responsible for quality assurance operations in the Rocky Mount, North Carolina area for seven years.
Experience at Lonza
At Lonza, Fred Billingsley held two key positions. He was the Head of QA Media Operations from 2020 to 2022, managing quality assurance for media operations in Walkersville, Maryland. Prior to this, he worked as a Quality Compliance Supervisor from 2005 to 2012, overseeing compliance and quality standards for seven years.
Background in Quality Assurance at Baxter BioScience
Fred Billingsley began his career in quality assurance at Baxter BioScience, where he worked as a Quality Coordinator from 2001 to 2005. During this time, he also held the role of Senior QA Fill/Finish Inspector, contributing to quality control processes for four years.
Educational Background
Fred Billingsley studied at The University of Texas at El Paso, where he earned a degree in English Literature and Business Management from 1989 to 1993. He also attended Colorado Technical University, where he achieved a Bachelor's degree in Business Administration and Management.